Actionable insights straight to your inbox

Equities logo

Philip Morris To Acquire UK Pharma Vectura for $1.4 Billion, Topping Carlyle’s Bid

The deal is the cigarette maker's second international acquisition in the past week, after agreeing to buy Fertin Pharma.
After-tax distributable earnings rose to $355.3 million, with depreciation in the private equity portfolio offset by gains in global infrastructure funds.